KLAS report: Positive ROI for digital breast tomo

Market research firm KLAS has found that providers using digital breast tomosynthesis reported a positive return on investment (ROI), despite a lack of reimbursement.

The new report, titled "Breast Tomosynthesis 2013: The Business Case," included interviews with 44 providers, 43 of which said they would buy a tomosynthesis unit again, despite the unpredictable reimbursement environment.

In all, 89% of survey respondents said that digital breast tomosynthesis is helping them achieve a positive return on investment through new patients and referrals, while 39% cited fewer callbacks for false positives and 11% cited patient satisfaction, according to KLAS.

Page 1 of 569
Next Page